VISTAGEN THERAPEUTICS INC's ticker is VTGN and the CUSIP is 92840H202. A total of 84 filers reported holding VISTAGEN THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $1,559 | +21.0% | 12,500 | 0.0% | 0.00% | 0.0% |
Q4 2022 | $1,288 | -35.6% | 12,500 | 0.0% | 0.00% | -50.0% |
Q3 2022 | $2,000 | -98.3% | 12,500 | -86.8% | 0.00% | -97.0% |
Q1 2022 | $117,000 | -36.4% | 94,500 | 0.0% | 0.07% | -32.7% |
Q4 2021 | $184,000 | -29.0% | 94,500 | 0.0% | 0.10% | -35.5% |
Q3 2021 | $259,000 | – | 94,500 | – | 0.15% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ACUTA CAPITAL PARTNERS, LLC | 11,728,033 | $36,943,000 | 14.76% |
VR Adviser, LLC | 16,047,286 | $50,549,000 | 6.13% |
COMMODORE CAPITAL LP | 3,331,315 | $10,494,000 | 3.66% |
Ghost Tree Capital, LLC | 2,000,000 | $6,300,000 | 1.73% |
EPIQ PARTNERS, LLC | 932,956 | $2,939,000 | 1.47% |
SPHERA FUNDS MANAGEMENT LTD. | 4,080,673 | $12,854,000 | 0.87% |
SILVERARC CAPITAL MANAGEMENT, LLC | 615,547 | $1,939,000 | 0.86% |
HighVista Strategies LLC | 308,096 | $971,000 | 0.69% |
NEA Management Company, LLC | 16,302,596 | $51,353,000 | 0.67% |
Nicholas Investment Partners, LP | 2,753,880 | $8,675,000 | 0.54% |